Stigmatizing Smoking: An Effective Deterrent?

Topics: Prevention | Public health | Stigma | Tobacco use disorder

Review of: Cortland CI et al, Addiction 2019;114:1842–1848 Tobacco use is the single most preventable cause of death, disease, and disability in the United States. Among the $50 million the American government spends each year on tobacco cessation efforts, part of that money is spent on public service campaigns that work to shame or stigmatize smok

Efficacy and Acceptability of Varenicline for Alcohol Use Disorder

Topics: Alcohol | Alcohol use disorder | Pharmacology | Tobacco use disorder | Varenicline

REVIEW OF: Oon-Arom A et al, Drug Alcohol Depend 2019;205:1–9 Varenicline, a partial agonist of one of the nicotinic receptors, is approved for the treatment of tobacco use disorder and has also been found to decrease alcohol use in some individuals who smoke. Naltrexone, acamprosate, and disulfiram are FDA approved and effective for alcohol use di